SunTrust Robinson Humphrey
https://www.suntrustrh.com/r.ashx?pid=3SunTrust Robinson Humphrey is the investment banking division of SunTrust Banks (NYSE: STI). To serve the needs of corporate clients across the nation, the firm’s services include capital raising, strategic advisory, risk management, and investment solutions. It also offers fixed income, equity research, and sales and trading to institutional investors.
View Older Stories View More Recent Stories
-
Steel Partners Holdings Announces New $600 Million Credit Facility
-
Sage Therapeutics (SAGE) PT Raised to $116 at SunTrust Robinson Humphrey
-
Midstates Petroleum (MPO) Reports Q3 EPS of $0.14
-
Appian Corporation (APPN) Launches 3.8M Follow-On Offering of Class A Common Stock
-
Appian Corporation Announces Launch of Follow-On Offering
-
Midstates Petroleum Announces Third Quarter 2017 Results
-
SRC Energy Inc. Closes Common Stock Offering and Announces Full Exercise of Underwriters’ Option
-
Pfizer creates chief operating officer role for Bourla
-
Alibaba (BABA) Singles Day Shatters Old Records, Sets Up Well for Q3 2018 - SunTrust
-
Compass Diversified (CODI) PT Lowered to $19 at SunTrust Robinson Humphrey
-
UPDATE: SunTrust Robinson Humphrey Downgrades Esterline Tech (ESL) to Hold, 'The Never Ending Transition Story'
-
Brandywine Realty Trust Prices $100.0 Million of 3.950% 5-Year Guaranteed Notes and $450.0 Million of 3.950% 10-Year Guaranteed Notes
-
Buckeye Partners, L.P. Prices $400 Million Offering of Senior Notes
-
Regeneron Pharma (REGN) PT Raised to $440 at SunTrust Robinson Humphrey
-
Freddie Mac Announces Pricing of $280 Million Multifamily Small Balance Loan Securitization
-
SRC Energy Inc. (SRCI) Prices 35M Share Common Offering
-
SRC Energy Inc. Announces Pricing of Common Stock Offering
-
Buckeye Partners, L.P. Announces Offering of Senior Notes
-
TG Therapeutics (TGTX) PT Raised to $36 at SunTrust Robinson Humphrey; Catalyst Rich 6-18 Months
-
SAGE Therapeutics (SAGE): Primary Endpoints in Both Phase III PPD Trials Met - Suntrust
-
UPDATE: SunTrust Robinson Humphrey Upgrades Intra-Cellular Therapies (ITCI) to Buy
-
SunTrust Robinson Humphrey Starts Abeona Therapeutics (ABEO) at Buy
-
SunTrust Robinson Humphrey Downgrades Amplify Snack Brands (BETR) to Hold
-
AutoNation Announces Pricing of $750 Million Aggregate Principal Amount of Senior Notes
-
Supernus Pharma (SUPN) Defended at SunTrust: 'Buy On Weakness'
-
Bluegreen Vacations Corp. (BXG) and Parent Company, BBX Capital Corp. (BBX), Announce Proposed 6.5M Share IPO Between $16-$18/Sh
-
Bluegreen Vacations Launches Roadshow for its Proposed Initial Public Offering
-
Merchants Bancorp Announces Exercise of the Underwriters' Option
-
Eldorado Resorts to Participate in Four Upcoming Institutional Investor Conferences
-
bluebird bio (BLUE) PT Raised to $163 at SunTrust Robinson Humphrey
-
SunTrust Robinson Humphrey Downgrades Pandora (P) to Hold, 'Tunrnaround Will Take Time/Investment'
-
SunTrust Robinson Humphrey Downgrades Cogent Communications (CCOI) to Hold Citing Valuation & Traffic Concerns
-
Funko (FNKO) IPO Opens Down 33%
-
Pre-Open Movers 11/02: (ESIO) (NBIX) (EYES) Higher; (PI) (NWL) (W) Lower (more...)
-
UPDATE: SunTrust Robinson Humphrey Upgrades Juno Therapeutics (JUNO) to Buy, Potential Takeout Target
-
SunTrust Robinson Humphrey Upgrades Newpark Resources (NR) to Buy
-
Funko Inc. (FNKO) Prices 10.42M Share IPO at $12/Sh
-
Funko, Inc. Announces Pricing of Initial Public Offering
-
Corporate Capital Trust Prepares to List On New York Stock Exchange On Or Around Nov. 14, 2017
-
Envision Healthcare (EVHC) PT Lowered to $34 at SunTrust Robinson Humphrey
-
SunTrust Robinson Humphrey Downgrades Under Armour, Inc. (UAA) to Hold
-
Merchants Bancorp Announces Closing of Its Initial Public Offering
-
UPDATE: SunTrust Robinson Humphrey Downgrades Nautilus (NLS) to Hold
-
Pfizer expects broad interest for consumer health business
-
CyrusOne Reports Third Quarter 2017 Earnings
-
Pre-Open Movers 10/30: (CAA) (ADMS) (DYN) Higher; (PSTI) (CTB) (CENX) Lower (more...)
-
Lifepoint Holdings (LPNT) PT Lowered to $54 at SunTrust Robinson Humphrey
-
SunTrust Robinson Humphrey Upgrades Bristol-Myers Squibb Co. (BMY) to Buy
-
ICON plc (ICLR) PT Raised to $138 at SunTrust Robinson Humphrey
-
Cerner (CERN) PT Lowered to $75 at SunTrust Robinson Humphrey

